Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | EGFR | P00533 | 1/20 | 0.48 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.48 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.47 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10407331 | 0.95 | KMT2A (0.60) | KMT2ASMN1; SMN2MEN1ALDH1A1MAPK1 | |
| SCHEMBL28188561 | 0.93 | EGFR (0.56) | KMT2ASMN1; SMN2MEN1ALDH1A1MAPK1 | |
| SCHEMBL17138156 | 0.93 | KMT2A (0.61) | KMT2ASMN1; SMN2MEN1ALDH1A1MAPK1 | |
| SCHEMBL9716543 | 0.93 | KMT2A (0.61) | KMT2ASMN1; SMN2MEN1ALDH1A1MAPK1 | |
| SCHEMBL17138195 | 0.93 | KMT2A (0.61) | KMT2ASMN1; SMN2MEN1ALDH1A1MAPK1 | |
| SCHEMBL17138196 | 0.93 | KMT2A (0.61) | KMT2ASMN1; SMN2MEN1ALDH1A1MAPK1 | |
| SCHEMBL28584208 | 0.92 | PLA2G4B (0.53) | KMT2ASMN1; SMN2MEN1ALDH1A1MAPK1 | |
| SCHEMBL572371 | 0.91 | LMNA (0.59) | KMT2ASMN1; SMN2MEN1ALDH1A1MAPK1 | |
| SCHEMBL4079668 | 0.90 | CYP3A4 (0.57) | KMT2ASMN1; SMN2MEN1ALDH1A1MAPK1 | |
| SCHEMBL421378 | 0.89 | BCL9 (0.53) | KMT2ASMN1; SMN2MEN1ALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | RNS CO.,LTD. (KR) | 2015-10-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | HRH3, CBR3, H1-0 | KMT2A 580/4885SMN1; SMN2 1635/4885MEN1 4684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.